|
rs6313
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The Association between 5HT2A T102C and Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease: A Meta-Analysis.
|
29349076 |
2017 |
|
rs6313
|
|
|
0.030 |
GeneticVariation |
BEFREE |
This study suggests a mechanism for the generation of different neuropsychiatric symptoms in AD from a single nucleotide polymorphism with reduced receptor binding in T102C 5-HT2A receptor gene homozygotes correlating with susceptibility to depressive symptoms, whereas the relative preservation of receptor binding in heterozygotes with AD correlating with susceptibility to hallucinations.
|
17481814 |
2007 |
|
rs6313
|
|
|
0.030 |
GeneticVariation |
BEFREE |
5-HT2A T102C receptor polymorphism and neuropsychiatric symptoms in Alzheimer's disease.
|
15211529 |
2004 |
|
rs6265
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Thus, the BDNF Val66Met polymorphism exerts an increase in glutamatergic transmission but impairs synaptic plasticity in the dorsal striatum, which might play a role in its effect on neuropsychiatric symptoms.
|
27378336 |
2017 |
|
rs759834365
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Thus, the BDNF Val66Met polymorphism exerts an increase in glutamatergic transmission but impairs synaptic plasticity in the dorsal striatum, which might play a role in its effect on neuropsychiatric symptoms.
|
27378336 |
2017 |
|
rs6265
|
|
|
0.020 |
GeneticVariation |
BEFREE |
In the present study, we examined whether neuropsychiatric symptoms were correlated with plasma brain-derived neurotrophic factor (BDNF) levels as a state marker or were associated with the BDNF polymorphism Val66Met in patients with amnestic mild cognitive impairment (A-MCI) or Alzheimer disease (AD).
|
24253237 |
2014 |
|
rs759834365
|
|
|
0.020 |
GeneticVariation |
BEFREE |
In the present study, we examined whether neuropsychiatric symptoms were correlated with plasma brain-derived neurotrophic factor (BDNF) levels as a state marker or were associated with the BDNF polymorphism Val66Met in patients with amnestic mild cognitive impairment (A-MCI) or Alzheimer disease (AD).
|
24253237 |
2014 |
|
rs78029637
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The overall benefit of DBS in SNCA, GBA and LRRK2 p.T2031S mutations may be compromised due to rapid progression of cognitive and neuropsychiatric symptoms.
|
30659355 |
2020 |
|
rs7136446
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Patients carrying minor alleles of rs7136446 and rs972936 showed more dizziness and multiple neuropsychiatric symptoms after brain injury.
|
31787098 |
2019 |
|
rs972936
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Patients carrying minor alleles of rs7136446 and rs972936 showed more dizziness and multiple neuropsychiatric symptoms after brain injury.
|
31787098 |
2019 |
|
rs56164415
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The other frequently studied <i>BDNF</i> polymorphism, C270T (rs56164415), has been associated with the development of different neuropsychiatric symptoms/disorders.
|
30542302 |
2018 |
|
rs4680
|
|
|
0.010 |
GeneticVariation |
BEFREE |
These findings support the hypothesis of a broad effect of the Val158Met polymorphism in the COMT gene on several dimensions of behavior and neuropsychiatric symptoms.
|
28235603 |
2017 |
|
rs28934908
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Adolescent onset cognitive regression and neuropsychiatric symptoms associated with the A140V MECP2 mutation.
|
24328834 |
2014 |